Valion Bio, Inc. Financial Ratios
VBIO|FY2024 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2024 SEC 10-K data.
Key Data Points
- Altman Z-Score -10.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2024)
Return on Equity
-230.3%
Profit Margin
-701.0%
Net Income / Revenue
Asset Turnover
0.42
Revenue / Total Assets
Equity Multiplier
0.78
Total Assets / Equity
Composite: -230.3% (reported: -230.3%)
Profitability
Liquidity
Current Ratio
9.70
Quick Ratio
8.53
Solvency
Interest Coverage
-8511.00
Efficiency
Asset Turnover
0.42
Inventory Turnover
2.79
Days Sales Outstanding
21 days
As of FY2024 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
+6.7%
+29.5pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.